2024-09-02 - Analysis Report
## HCA Stock Analysis Report

**Company Overview:** HCA Healthcare, Inc. is a leading provider of healthcare services in the United States.

**1. Performance Analysis:**

* **Cumulative Return:** HCA has achieved a cumulative return of 170.42%, significantly outperforming the S&P 500 (VOO) with a cumulative return of 89.66%. This represents a difference of 80.76%, indicating strong performance compared to the benchmark.
* **Relative Outperformance:**  The current relative outperformance is at 100%, indicating that HCA is at its highest point of outperformance compared to its historical performance.

**2. Recent Price Movement:**

* **Closing Price:** $395.59
* **5-Day Moving Average:** $391.45
* **20-Day Moving Average:** $373.99
* **60-Day Moving Average:** $348.09

The price is currently trading above all moving averages, indicating a bullish trend.

**3. Technical Indicators:**

* **RSI (Relative Strength Index):** 99.19 – Extremely overbought, suggesting potential for a near-term correction.
* **PPO (Percentage Price Oscillator):** 0.22 –  A positive value indicates a bullish momentum, although the extremely high RSI level might point towards overbought conditions.
* **Delta_Previous_Relative_Divergence:** 1.17 – The positive value suggests short-term upward momentum.
* **Expected Return:** 0.0% - This is the estimated maximum return over the next 5 years based on current investment levels.

**4. Recent Earnings & Outlook:**

| Date         | EPS     | Revenue       |
|--------------|---------|---------------|
| 2024-07-29  | 5.6    | 17.49 B$     |
| 2024-05-02  | 6.01   | 17.34 B$     |
| 2023-10-26  | 3.98   | 16.21 B$     |
| 2023-08-02  | 4.35   | 15.86 B$     |
| 2024-07-29  | 4.35   | 15.86 B$     |

The most recent earnings report showed EPS of 5.6, exceeding expectations, and revenue of 17.49 billion dollars. HCA has consistently demonstrated strong revenue growth and profitability, indicating a healthy financial performance. 

**5. Overall Analysis:**

HCA stock has delivered strong outperformance compared to the S&P 500, and its recent price movement indicates a bullish trend. However, the extremely overbought conditions suggested by RSI might suggest a potential correction in the near term. Despite this, the company has consistently shown strong financial performance with solid earnings and revenue growth. 

**6. Conclusion:**

HCA's current performance is highly impressive, exceeding the market benchmark significantly. While the technical indicators suggest potential near-term corrections, the company's solid financial performance and strong growth prospects offer a compelling opportunity for long-term investment. However, investors should be aware of the potential for short-term volatility and consider carefully before making any investment decisions. 
